allogenic
| 5 min read
Aurion Biotech's manufacturing approach to unmodified allogeneic corneal endothelial cells offers a set of hard-won lessons for a cell therapy field still working out how to get from proof-of-concept to broad patient access.
| 8 min read
A new approach to cell engineering could make off-the-shelf CAR T cell therapies a reality.
Page 1 of 1 - 2 Total Items
